These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33719846)

  • 41. [Induction of Apoptosis of Human Cisplatin-resistance Lung Cancer Cells with MPPa-photodynamic Therapy].
    Luo L; Yu T; Bai D; Hu L
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Aug; 33(4):729-34. PubMed ID: 29714913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Silence of fibronectin 1 increases cisplatin sensitivity of non-small cell lung cancer cell line.
    Gao W; Liu Y; Qin R; Liu D; Feng Q
    Biochem Biophys Res Commun; 2016 Jul; 476(1):35-41. PubMed ID: 27207836
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bcl-XL small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma cells.
    Lei X; Huang Z; Zhong M; Zhu B; Tang S; Liao D
    Acta Biochim Biophys Sin (Shanghai); 2007 May; 39(5):344-50. PubMed ID: 17492131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The roles of holothurian glycosaminoglycan combined with cisplatin on proliferation and chemotherapeutic response in A549 human lung adenocarcinoma cell].
    Jin Q; Zhu XH; Lin CZ; Zhang H; Cao YW; Ding XQ; Lyu ZH
    Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):252-257. PubMed ID: 29730910
    [No Abstract]   [Full Text] [Related]  

  • 45. Bcl-2 small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma A549/DDP cell to cisplatin and diallyl disulfide.
    Huang Z; Lei X; Zhong M; Zhu B; Tang S; Liao D
    Acta Biochim Biophys Sin (Shanghai); 2007 Nov; 39(11):835-43. PubMed ID: 17989874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiR-192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF-κB pathway.
    Li Y; Zu L; Wu H; Zhang F; Fan Y; Pan H; Du X; Guo F; Zhou Q
    Thorac Cancer; 2022 Feb; 13(3):430-441. PubMed ID: 34953057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells.
    Xu W; Chen Q; Wang Q; Sun Y; Wang S; Li A; Xu S; Røe OD; Wang M; Zhang R; Yang L; Zhou J
    Cell Death Dis; 2014 Dec; 5(12):e1551. PubMed ID: 25476899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of Holothurian Glycosaminoglycan on the Sensitivity of Lung Cancer to Chemotherapy.
    Lin C; Zhu X; Jin Q; Sui A; Li J; Shen L
    Integr Cancer Ther; 2020; 19():1534735420911430. PubMed ID: 32202167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The combination therapy of HIF1α inhibitor LW6 and cisplatin plays an effective role on anti-tumor function in A549 cells.
    Mai L; Luo M; Wu JJ; Yang JH; Hong LY
    Neoplasma; 2019 Sep; 66(5):776-784. PubMed ID: 31169018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apatinib resensitizes cisplatin-resistant non-small cell lung carcinoma A549 cell through reversing multidrug resistance and suppressing ERK signaling pathway.
    Liu ZL; Jin BJ; Cheng CG; Zhang FX; Wang SW; Wang Y; Wu B
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5370-5377. PubMed ID: 29243778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression.
    Sui C; Meng F; Li Y; Jiang Y
    J Transl Med; 2015 Apr; 13():132. PubMed ID: 25927928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance.
    Xu W; Zhou B; Zhao X; Zhu L; Xu J; Jiang Z; Chen D; Wei Q; Han M; Feng L; Wang S; Wang X; Zhou J; Jin H
    Int J Biol Sci; 2018; 14(9):1122-1132. PubMed ID: 29989047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FAM60A promotes cisplatin resistance in lung cancer cells by activating SKP2 expression.
    Hou Q; Jiang Z; Li Y; Wu H; Yu J; Jiang M
    Anticancer Drugs; 2020 Sep; 31(8):776-784. PubMed ID: 32796403
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-218 regulates cisplatin (DPP) chemosensitivity in non-small cell lung cancer by targeting RUNX2.
    Xie J; Yu F; Li D; Zhu X; Zhang X; Lv Z
    Tumour Biol; 2016 Jan; 37(1):1197-204. PubMed ID: 26282001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ARL6IP5 reduces cisplatin-resistance by suppressing DNA repair and promoting apoptosis pathways in ovarian carcinoma.
    Kim JY; Bahar E; Lee JY; Chang S; Kim SH; Park EY; Do SI; Yoon H; Kim HS
    Cell Death Dis; 2022 Mar; 13(3):239. PubMed ID: 35293383
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
    Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM
    Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [RNA interference silencing excision repair cross-complementing 1 gene and affecting cisplatin sensitivity on lung cancer cell lines].
    Shang XB; Yu ZT; Tang P; Zhang XZ
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(39):2799-802. PubMed ID: 19080461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apurinic endonuclease 1 promotes the cisplatin resistance of lung cancer cells by inducing Parkin‑mediated mitophagy.
    Li Z; Wang Y; Wu L; Dong Y; Zhang J; Chen F; Xie W; Huang J; Lu N
    Oncol Rep; 2019 Dec; 42(6):2245-2254. PubMed ID: 31578585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effects of shRNA on Cisplatin-resistant Non-small Cell Lung Cancer Cell A549 via Silencing
    He L; Du ZD; Wang Y; Meng RQ; Zhao WW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):312-319. PubMed ID: 32543135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
    Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
    Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.